{"database": "lobbying", "table": "lobbying_activities", "rows": [[3138586, "ca351427-ce8d-4a70-805e-e13ac3dc1ded", "Q1", "HELIX, INC.", 401106164, "HELIX, INC.", 2024, "first_quarter", "MED", "Oversight of Lab Developed Tests, express legislative authority. Viral Surveillance in clinical settings.", "Centers For Disease Control & Prevention (CDC),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE", null, 83000, 0, 0, "2024-04-01T11:07:53-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["3138586"], "units": {}, "query_ms": 16.979168023681268, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}